Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

A Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma

NCT04458272

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Kitasato University Hospital Sagamihara, Kanagawa, Japan
  • Tohoku University Hospital Sendai, Miyagi, Japan
  • Saitama Medical University International Medical Center Hidaka, Saitama, Japan
View Trial Details
Active, Not Recruiting

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

NCT04211337

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Hematology/Oncology - Westwood (Building 100) Los Angeles, California, United States
  • University of California Davis (UC Davis) Comprehensive Cancer Center Sacramento, California, United States
View all 143 locations
View Trial Details
Active, Not Recruiting

Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers

NCT02375841

Conditions
Astrocytoma, Behavior, Brain Cancer, +17 more
Locations
  • Henry Ford Hospital Detroit, Michigan, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG

NCT05610891

Conditions
Glioma, High-Grade Glioma, Neoplasms, +6 more
Locations
  • Stanford University Palo Alto, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

NCT03478462

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +62 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Duke University Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Active, Not Recruiting

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

NCT05907954

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Moores Cancer Center La Jolla, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 18 locations
View Trial Details

Related conditions